1. Japan Stocks

  2. •

    Producer manufacturing

  3. •

    Industrial machinery
Horiba, Ltd.

Horiba, Ltd.

22,380.00
JPY
-890.00
(-3.82%)
1.15TMarket Cap
Nov 13Next Earn
Horiba, Ltd.
TSE:6856
(Tokyo Stock Exchange)

Recent

price

22,380.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
JPY
2,803.47
2,919
2,780.55
3,265.7
3,617.79
4,080.03
4,038.2
4,635.91
4,994.31
4,747.97
4,434.02
5,315.88
6,398.45
6,875.79
7,553.14
7,934.13
- -
Revenue per Share
187.45
204.85
174.86
212.75
250.28
315.22
307.73
386.27
529.22
367.07
312.57
505.04
807.04
953.71
799.44
883.5
- -
Basic EPS, GAAP
200.93
59.68
140.48
177.33
42.62
-55.61
59.28
385.99
219.58
324.94
407.85
537.86
518.33
177.03
497.12
672.71
- -
Free Cash Flow per Basic Share
13.01
20.03
45.94
53
66.96
69.49
72.6
94.95
125.92
144.88
109.9
109.89
164.83
259.67
291.02
269.74
- -
Dividend per Share
1,989.75
2,137.81
2,352.21
2,707.77
2,937.97
3,022.83
3,159.74
3,576.66
3,839.44
4,068.71
4,233.95
4,845.79
5,702.86
6,711.97
7,501.05
8,300.83
8,691.28
Book Value per Share
1,862.77
2,028.1
2,246.06
2,586.97
2,787.82
2,778.18
2,971.68
3,472.35
3,723.22
3,937.48
4,124.34
4,740.97
5,617.78
6,594.51
7,370.36
8,147.36
8,536.71
Tangible Book Value per Share
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
Basic Weighted Avg Shares
118,556
123,456
117,609
138,136
153,065
171,916
170,093
195,399
210,570
200,241
187,080
224,314
270,133
290,558
317,369
333,081
- -
Sales/Revenue/Turnover
10.38
12.07
9.99
9.94
11.25
11.72
10.88
13.73
13.7
10.45
10.53
14.29
16.97
16.28
15.23
15.92
- -
Operating Margin (%)
4,523
4,145
3,743
4,278
4,904
6,109
6,815
7,533
7,240
8,794
9,618
10,440
11,348
12,602
13,059
13,805
- -
Depreciation Expense
7,927
8,664
7,396
8,999
10,589
13,282
12,962
16,281
22,313
15,481
13,188
21,311
34,072
40,302
33,591
37,090
- -
Net Income, GAAP
33.29
36.51
33.79
33.85
34.9
32.93
24.81
33.16
22.75
25.2
29.93
29.44
27.92
24.95
31.19
27.35
- -
Effective Tax Rate (%)
6.69
7.02
6.29
6.51
6.92
7.73
7.62
8.33
10.6
7.73
7.05
9.5
12.61
13.87
10.58
11.14
- -
Profit Margin (%)
62,429
69,681
74,326
88,097
90,677
85,779
90,736
103,109
109,894
128,081
151,162
155,905
184,318
217,526
236,518
234,251
240,720
Working Capital
11,195
11,291
12,113
17,576
17,209
31,826
34,255
33,704
32,028
46,878
67,518
55,077
54,854
54,699
55,391
39,294
38,984
LT Debt
84,155
90,458
99,534
114,543
124,312
127,242
133,190
150,864
162,017
171,613
178,667
204,491
240,848
283,730
314,702
348,638
365,262
Total Equity
7.92
8.79
6.78
6.97
7.47
8.1
7.78
9.41
10.9
6.9
5.48
8.19
10.84
10.64
9.03
9.54
- -
Return on Invested Capital (%)
8.28
8.58
6.84
7.36
7.52
8.53
7.61
8.88
11.34
7.06
5.43
8.02
11.66
12.53
9.46
9.49
- -
Return on Capital (%)
9.66
9.93
7.79
8.41
8.87
10.56
9.96
11.47
14.27
9.28
7.53
11.12
15.3
15.37
11.23
11.18
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
11,830
- -
23,901
LT Borrowings
55,034
- -
38,984
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
42
42
Market Capitalization
544,545
750,256
1,151,811

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
327,840
- -
365,584
Cash, Cash Equivalents & STI
136,404
- -
170,939
Accounts Receivable, Net
69,568
- -
82,836
Inventories
109,806
- -
98,840
Total Current Liabilities
99,663
- -
124,864
Payables & Accruals
- -
- -
- -
ST Debt
11,830
- -
23,901
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.71%
14.35%
10.78%
Free Cash Flow
55.24%
35.38%
35.2%
Net Income, GAAP
14.83%
26.7%
10.42%
Sales/Revenue/Turnover
7.22%
12.41%
4.95%
Total Cash Common Dividend
- -
- -
-7.39%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70,252
72,468
- -
- -
317,369
2025
- -
- -
- -
- -
333,081
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
166.55
145.86
- -
- -
799.44
2025
- -
- -
- -
- -
883.5
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
291.02
2025
- -
- -
- -
- -
269.74
2026
- -
- -
- -
- -
- -
Similar Companies
Applied Materials, Inc. (NASDAQ:AMAT)
Oklo Inc. (NYSE:OKLO)
Lam Research Corporation (NASDAQ:LRCX)
Tokyo Electron Ltd. (TSE:8035)
Welspun Corp Limited (NSE:WELCORP)
Symbotic Inc. (NASDAQ:SYM)
Business
HORIBA, Ltd. (6856.T) manufactures and sells advanced analytical and measurement instruments and systems worldwide. The company operates through five primary segments—Automotive, Process/Environment, Medical, Semiconductor, and Scientific—offering engine emission measurement devices; in-use, on-board, and in-vehicle exhaust gas analyzers; driveline, brake, fuel cell, and battery test systems; environmental monitoring instruments for water quality, air quality, and industrial processes; in-vitro medical diagnostic analyzers including hematology systems and reagents; semiconductor wafer inspection systems, mass flow controllers, and process control equipment; as well as scientific spectrometers, Raman instruments, and fluorescence spectroscopy solutions for R&D, quality control, and applications in life sciences, materials, energy, and pharmaceuticals. HORIBA serves diverse sectors including automotive R&D, energy solutions, semiconductor manufacturing, medical diagnostics, and environmental management, with target markets encompassing hydrogen energy, connected vehicles, power generation, food and beverages, and waste management. Founded in 1945 and headquartered in Kyoto, Japan, the company maintains extensive global operations across more than 20 countries including the United States, China, Germany, India, Malaysia, and the United Kingdom. Recent developments include the acquisition of EtaMax Co., Ltd. in South Korea in 2025 to bolster semiconductor wafer inspection capabilities through integration of spectroscopy and defect detection technologies; establishment of a new production base in Kedah, Malaysia, by subsidiary HORIBA Malaysia Sdn Bhd, with operations commencing in January 2026 to strengthen the global supply chain for semiconductor products; opening of a medical equipment manufacturing facility in Nagpur, India, focused on hematology reagents and mass flow controllers with plans for further expansion into neighboring countries; and reporting consolidated net sales of 317,369 million yen for the year ended December 31, 2024, alongside 8,955 consolidated employees.

Company News

Company News APIChatGPT

  • businesswire.com

    Oasis Views HORIBA's 2026 AGM Results as Clear Warning to the Board

  • businesswire.com

    Oasis Calls on HORIBA Shareholders to Vote Against Chairman Atsushi Horiba at the 2026 Annual General Meeting

  • defenseworld.net

    Contrasting Horiba (OTCMKTS:HRIBF) and JE Cleantech (NASDAQ:JCSE)

  • defenseworld.net

    Horiba (OTCMKTS:HRIBF) versus Global Industrial (NYSE:GIC) Critical Analysis

  • defenseworld.net

    Analyzing DMC Global (NASDAQ:BOOM) & Horiba (OTCMKTS:HRIBF)

  • defenseworld.net

    Analyzing Horiba (OTCMKTS:HRIBF) & DMC Global (NASDAQ:BOOM)

  • defenseworld.net

    Comparing Horiba (OTCMKTS:HRIBF) & Presidio Property Trust (NASDAQ:SQFT)

  • defenseworld.net

    Financial Contrast: Kion Group (OTCMKTS:KIGRY) and Horiba (OTCMKTS:HRIBF)

  • thelincolnianonline.com

    Comparing Horiba (OTCMKTS:HRIBF) & Pressure Biosciences (OTCMKTS:PBIO)